These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 3554991)

  • 1. Levamisole in Crohn's disease: a randomized, double-blind, placebo-controlled clinical trial.
    Sachar DB; Rubin KP; Gumaste V
    Am J Gastroenterol; 1987 Jun; 82(6):536-9. PubMed ID: 3554991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of levamisole on the prevention of developmental flare-ups in quiescent Crohn's disease: a prospective multicenter controlled trial in 155 patients].
    Modigliani R; Pieddeloup C; Hecketsweiler P; Descos L; Lerebours E; Vernisse B; Costil V; Bitoun A; Lacroute JM; Maire P
    Gastroenterol Clin Biol; 1983; 7(8-9):683-92. PubMed ID: 6352383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Cooperative Crohn's Disease Study: study design and conduct of the study.
    Winship DH; Summers RW; Singleton JW; Best WR; Becktel JM; Lenk LF; Kern F
    Gastroenterology; 1979 Oct; 77(4 Pt 2):829-42. PubMed ID: 38175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease.
    Brynskov J; Freund L; Rasmussen SN; Lauritsen K; de Muckadell OS; Williams N; MacDonald AS; Tanton R; Molina F; Campanini MC
    N Engl J Med; 1989 Sep; 321(13):845-50. PubMed ID: 2671739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result.
    Ursing B; Alm T; Bárány F; Bergelin I; Ganrot-Norlin K; Hoevels J; Huitfeldt B; Järnerot G; Krause U; Krook A; Lindström B; Nordle O; Rosén A
    Gastroenterology; 1982 Sep; 83(3):550-62. PubMed ID: 6124474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimycobacterial therapy in Crohn's disease: results of a controlled, double-blind trial with a multiple antibiotic regimen.
    Prantera C; Kohn A; Mangiarotti R; Andreoli A; Luzi C
    Am J Gastroenterol; 1994 Apr; 89(4):513-8. PubMed ID: 8147352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A trial of sulfasalazine as adjunctive therapy in Crohn's disease.
    Singleton JW; Summers RW; Kern F; Becktel JM; Best WR; Hansen RN; Winship DH
    Gastroenterology; 1979 Oct; 77(4 Pt 2):887-97. PubMed ID: 38179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double blind randomized prospective trial of levamisole/placebo in stage I cutaneous malignant melanoma.
    Loutfi A; Shakr A; Jerry M; Hanley J; Shibata HR
    Clin Invest Med; 1987 Jul; 10(4):325-8. PubMed ID: 3308241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo.
    Agarwal S; Ramam M; Sharma VK; Khandpur S; Pal H; Pandey RM
    Br J Dermatol; 2005 Jul; 153(1):163-6. PubMed ID: 16029343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma.
    Spitler LE; Sagebiel R
    N Engl J Med; 1980 Nov; 303(20):1143-7. PubMed ID: 6999349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study.
    Present DH; Korelitz BI; Wisch N; Glass JL; Sachar DB; Pasternack BS
    N Engl J Med; 1980 May; 302(18):981-7. PubMed ID: 6102739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial.
    Arora S; Katkov W; Cooley J; Kemp JA; Johnston DE; Schapiro RH; Podolsky D
    Hepatogastroenterology; 1999; 46(27):1724-9. PubMed ID: 10430331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind placebo-controlled evaluation of levamisole in chronic rheumatoid arthritis.
    Franchimont P; Heynen G; Berghs H; Remans J; Vroninks P
    Scand J Rheumatol; 1979; 8(1):43-8. PubMed ID: 373088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease.
    Mansfield JC; Parkes M; Hawthorne AB; Forbes A; Probert CS; Perowne RC; Cooper A; Zeldis JB; Manning DC; Hawkey CJ
    Aliment Pharmacol Ther; 2007 Aug; 26(3):421-30. PubMed ID: 17635377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study.
    Omer B; Krebs S; Omer H; Noor TO
    Phytomedicine; 2007 Feb; 14(2-3):87-95. PubMed ID: 17240130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levamisole therapy in atopic dermatitis: randomized double-blind evaluation.
    White CR; Hanifin JM
    Arch Dermatol; 1978 Sep; 114(9):1314-5. PubMed ID: 356738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levamisole treatment in ulcus cruris. A double-blind placebo-controlled study.
    Morias J; Peremans W; Campaert H; Mertens RL
    Arzneimittelforschung; 1979; 29(7):1050-2. PubMed ID: 387047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Cooperative Crohn's Disease Study: results of drug treatment.
    Summers RW; Switz DM; Sessions JT; Becktel JM; Best WR; Kern F; Singleton JW
    Gastroenterology; 1979 Oct; 77(4 Pt 2):847-69. PubMed ID: 38176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease.
    Reinisch W; Panés J; Lémann M; Schreiber S; Feagan B; Schmidt S; Sturniolo GC; Mikhailova T; Alexeeva O; Sanna L; Haas T; Korom S; Mayer H
    Am J Gastroenterol; 2008 Sep; 103(9):2284-92. PubMed ID: 18671816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
    Selby W; Pavli P; Crotty B; Florin T; Radford-Smith G; Gibson P; Mitchell B; Connell W; Read R; Merrett M; Ee H; Hetzel D;
    Gastroenterology; 2007 Jun; 132(7):2313-9. PubMed ID: 17570206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.